Longitudinal and Individual Symptom Analyses of Momelotinib and Ruxolitinib-Treated Myelofibrosis Patients from SIMPLIFY-1

Mesa R., Hudgens S., Floden L., Palmer J., Gupta V., McLornan D., McMullin MF., Kiladjian J-J., Foltz L., Platzbecker U., Fox LM., Mead A., Ross D., Oh S., Perkins A., Leahy MF., Deheshi S., Donahue R., Klencke B., Verstovsek S.

Type

Conference paper

Publication Date

2022

Volume

197

Pages

79 - 80

Permalink